Home Sensile Medical

Sensile Medical

Sensile Medical Forms a Strategic Alliance with Sanofi and Verily to Develop and Commercialize a Connected Insulin Patch Pump

6/26/18: “Our goal is to develop a new type of pump technology that is simple to use and appropriate for people with Type 2 diabetes, as well as by those with Type 1 diabetes who are the primary users of insulin pumps today,” said Derek Brandt, CEO of Sensile Medical.

First US FDA Submission of Wearable Drug-Device Combination Product Based on Sensile Medical’s SensePatch Drug Delivery Technology

Sensile Medical, a global leader in Large Volume Injector devices based on the cost-efficient and highly accurate SenseCore micro pump technology platform, today announced that scPharmaceuticals has submitted Furosemide for s.c. administration together with Sensile's patch pump delivery system for approval with the FDA.